1. |
Zhang LN, Wang XT, Ai YH, et al. Epidemiological features and risk factors of sepsis-associated encephalopathy in intensive care unit patients: 2008-2011[J]. Chin Med J (Engl), 2012, 125(5): 828-831.
|
2. |
Berg RM, Møller K, Bailey DM. Neuro-oxidative-nitrosative stress in sepsis[J]. J Cereb Blood Flow Metab, 2011, 31(7): 1532-1544.
|
3. |
Jacob A, Brorson JR, Alexander JJ. Septic encephalopathy: inflammation in man and mouse[J]. Neurochem Int, 2011, 58(4): 472-476.
|
4. |
Liu TF, Vachharajani V, Millet P, et al. Sequential actions of SIRT1- RELB-SIRT3 coordinate nuclear-mitochondrial communication during immunometabolic adaptation to acute inflammation and sepsis[J]. J Biol Chem, 2015, 290(1): 396-408.
|
5. |
Liu MW, Su MX, Zhang W, et al. Rhodiola rosea suppresses thymus T-lymphocyte apoptosis by downregulating tumor necrosis factor- α-induced protein 8-like-2 in septic rats[J]. Int J Mol Med, 2015, 36(2): 386-398.
|
6. |
Patel GP, Balk RA. Systemic steroids in severe sepsis and septic shock[J]. Am J Respir Crit Care Med, 2012, 185(2): 133-139.
|
7. |
Allen KS, Kinasewitz GT. The pendulum of corticosteroids in sepsis swings again?[J]. Crit Care Med, 2014, 42(11): 2442-2443.
|
8. |
Annane D, Bellissant E, Bollaert PE, et al. Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review[J]. JAMA, 2009, 301(22): 2362-2375.
|
9. |
Das T, Hoarau JJ, Jaffar Bandjee MC, et al. Multifaceted innate immune responses engaged by astrocytes, microglia and resident dendritic cells against Chikungunya neuroinfection[J]. J Gen Virol, 2015, 96(Pt 2): 294-310.
|
10. |
De los Reyes LM, Céspedes ÁE. Atorvastatin-meloxicam association inhibits neuroinflammation and attenuates the cellular damage in cerebral ischemia by arterial embolism[J]. Biomedica, 2014, 34(3): 366-378.
|
11. |
Araki K, Youngblood B, Ahmed R. The role of mTOR in memory CD8 T-cell differentiation[J]. Immunol Rev, 2010, 235(1): 234-243.
|
12. |
Su Y, Qu Y, Zhao F, et al. Regulation of autophagy by the nuclear factor κB signaling pathway in the hippocampus of rats with sepsis[J]. J Neuroinflammation, 2015, 12: 116.
|
13. |
Maramattom BV. Sepsis associated encephalopathy[J]. Neurol Res, 2007, 29(7): 643-646.
|
14. |
Sofroniew M. Vinters HV. Astrocytes:biology and pathology[J]. Acta Neuropathol, 2010, 119(1): 7-35.
|
15. |
Hennessy E, Griffin ÉW, Cunningham C. Astrocytes are primed by chronic neurodegeneration to produce exaggerated chemokine and cell infiltration responses to acute stimulation with the cytokines IL- 1β and TNF-α[J]. J Neurosci, 2015, 35(22): 8411-8422.
|
16. |
Kalashnyk O, Lykhmus O, Oliinyk O, et al. α7 nicotinic acetylcholine receptor-specific antibody stimulates interleukin-6 production in human astrocytes through p38-dependent pathway[J]. Int Immunopharmacol, 2014, 23(2): 475-479.
|
17. |
Bockaert J, Marin P. mTOR in brain physiology and pathologies[J]. Physiol Rev, 2015, 95(4): 1157-1187.
|
18. |
Gao S, Duan C, Gao G, et al. Alpha-synuclein overexpression negatively regulates insulin receptor substrate 1 by activating mTORC1/S6K1 signaling[J]. Int J Biochem Cell Biol, 2015, 64: 25-33.
|
19. |
Dáňová K, Klapetková A, Kayserová J, et al. NF-κB, p38 MAPK, ERK1/2, mTOR, STAT3 and increased glycolysis regulate stability of paricalcitol/dexamethasone-generated tolerogenic dendritic cells in the inflammatory environment[J]. Oncotarget, 2015, 6(16): 14123- 14138.
|
20. |
Xu Y, Li Z, Yin Y, et al. Ghrelin inhibits the differentiation of T helper 17 cells through mTOR/STAT3 signaling pathway[J]. PLoS One, 2015, 10(2): e0117081.
|
21. |
Park J, Kim M, Kang SG, et al. Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway[J]. Mucosal Immunol, 2015, 8(1): 80-93.
|
22. |
Minneci PC, Deans KJ, Banks SM, et al. Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dose[J]. Ann Intern Med, 2004, 141(1): 47-56.
|
23. |
Levy M, Antunes A, Fiette L, et al. Impact of corticosteroids on experimental meningococcal sepsis in mice[J]. Steroids, 2015, 101: 96-102.
|
24. |
Atkinson SJ, Cvijanovich NZ, Thomas NJ, et al. Corticosteroids and pediatric septic shock outcomes: a risk stratified analysis[J]. PLoS One, 2014, 9(11): e112702.
|
25. |
Casserly B, Gerlach H, Phillips GS, et al. Low-dose steroids in adult septic shock: results of the Surviving Sepsis Campaign[J]. Intensive Care Med, 2012, 38(12): 1946-1954.
|